Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Over time, we plan to and also expect our customers, to generate data that supports our belief that da Vinci 5 can improve time to proficiency for new surgeons adopting robotics and that the da Vinci platform can improve clinical outcomes |
| There's an opportunity here and one of the big steps forward in da Vinci 5 is really setting up surgical data science, the ability to have integrated high-quality synchronized data that allows a computation, plus sharp care teams to make really good decisions about what they're doing and how to improve |
| As we said in the prepared remarks, we also see the potential to improve the time for new surgeons to become proficient robot users and the potential to improve clinical outcomes |
| We believe, over the long term, that the potential for improved interoperative efficiency and higher procedure throughput using da Vinci 5 provide customers the opportunity to achieve a lower total cost to treat per patient episode compared to Xi |
| Intuitive continues our commitment to improving ergonomics with da Vinci 5, to enhancements that could improve care team satisfaction and enable higher productivity during a single operative day and over a career |
| Faster cases that don't compromise patient safety allow for more efficient use of precious human and capital resources at the hospital and should be well appreciated by our customers |
| But I think Xi is a highly capable system and I think we're really excited about the potential for da Vinci 5 but too early to say beyond that |
| Unwanted tremor and vibration filtration is the best we've ever brought to market |
| Second, da Vinci 5 has our highest quality and most natural 3D surgical imaging system we've developed to date |
| da Vinci 5 incorporates more than 150 design enhancements, including several standout innovations that we believe will drive the future of robotic-assisted surgery and provides significant benefits for surgeons, care teams, their patients and hospitals |
| It's healthy debate and we're excited to see where we and our customers go with it |
| On the -- one of the more interesting updates I saw was the improvement in processing power up to 10,000 more or x more processing power |
| That's going to require evidence to support but both opportunities also improve customer economics |
| da Vinci 5 may help that, especially if it's easy to learn and has better throughput over time |
| So we think the Xi research base is going to be a nice asset for the company |
| We plan to improve these margins over a multiyear period |
| We're excited to do so |
| Another important set of innovations Dave mentioned are design improvements to surgeon autonomy and workflow efficiencies |
| On the other hand, volumes are growing, efficiency programs continue |
| We design our products and services to improve patient outcomes, improve the patient and care team experiences and lower the total cost to treat |
| We think there's potential to increase throughput and efficiency, having surgeon autonomy so the surgeon can move forward more quickly with the change that they want to make in the OR as opposed to waiting for their nursing staff to get free and go over and do it |
| Rick Wise I'll offer my congratulations as well, very exciting |
| We're delighted to introduce our next generation multi-port platform, da Vinci 5 |
| And it will support future features, future integrations such as, for example, better integration of pre-optive images as we bring those into the surgical field and so it sets us up for our teams, our innovation teams internally to make a lot of progress over the coming years |
| We also know that it helps care teams -- half a system that's a little bit easier to use |
| It's very clear that there's significant value in using the Force Feedback needle driver |
| So the 10,000x compute power increase over Xi, it does support a lot of our foundational innovation that we described in our prepared remarks and it supports this expanding digital ecosystem that we discussed with simulator and hub and other aspects |
| Obviously, our sales force is excited to engage with customers on da Vinci 5 and expose customers to the relative differences in value |
| Fourth, in pursuit of more efficient workflow and greater surgeon autonomy, we've integrated a high-performance insufflator, our next-generation electrosurgical unit and optimize the user interface of da Vinci 5 |
| With respect to improving gross margins, our experience has been and we expect it to be similar with respect to da Vinci 5, it will take us several years to kind of optimize manufacturing and the supply chain and get our cost to target |
| Statement |
|---|
| As is typical and as we said, Rick, the gross margins will be below corporate average and below our target |
| Given the complexity of Force Feedback instruments at launch, gross margins will be significantly below the corporate average |
| Given the limited availability at the beginning, it's unlikely we're going to see very many excise |
| So there may be some headwinds here, where if they only have one to buy, it isn't a capacity issue |
| As we described in our last earnings call and consistent with our historical experience, we expect that da Vinci 5 system and Force Feedback instruments will start at lower gross margins and rise over a multiyear period as we build volume and optimize design, manufacturing and supply chains |
| Jamie, on the Q4 call, you said the Xi ramp was not a good analog |
| The dependency on Intuitive is significant relative to 2014 when we launched Xi |
| Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties |
| So I think we're going to have to see as we go through it |
| We do not expect a significant number of trade-ins during the limited launch period, given constrained supply |
| Musculoskeletal problems, repetitive motion issues and fatigue can impact surgeon longevity and we are all aware of the increasing need for surgeons around the world |
Please consider a small donation if you think this website provides you with relevant information